Defense Verdict is Latest Fosamax ONJ Trial
Written By: Rheingold, Valet, Rheingold, Ruffo & Giuffra LLP
The jury has come back with a defense verdict in the latest Fosamax osteonecrosis trial. The latest trial, which took place in the New Jersey state mass tort litigation, involved a woman who took Fosamax from 2002 to 2008 and developed osteonecrosis of the jaw (ONJ) after a dental procedure in October of 2007. This makes 4 defense verdicts to just 1 plaintiff verdict in all of the ONJ trials thus far. The defense has successfully argued that poor dental hygiene rather than bisphosphonates were the cause of the osteonecrosis that developed in all but one of the plaintiffs' cases.
Our firm is hundreds of patients who have been injured after taking the osteoporosis drug Fosamax, or other similiar bisphosphonate drugs like Boniva and Actonel. There are two separate litigations surrounding Fosamax: the ONJ litigation and the Femur Fracture litigation. With the ONJ cases have been tried with mixed results, there has yet to be a tral in the femur fracture litigation.